Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Privia Health (PRVA) EPS (Weighted Average and Diluted) (2020 - 2025)

Privia Health (PRVA) has 6 years of EPS (Weighted Average and Diluted) data on record, last reported at $0.08 in Q4 2025.

  • For Q4 2025, EPS (Weighted Average and Diluted) rose 166.67% year-over-year to $0.08; the TTM value through Dec 2025 reached $0.18, up 63.64%, while the annual FY2025 figure was $0.18, 63.64% up from the prior year.
  • EPS (Weighted Average and Diluted) reached $0.08 in Q4 2025 per PRVA's latest filing, up from $0.05 in the prior quarter.
  • Across five years, EPS (Weighted Average and Diluted) topped out at $0.16 in Q4 2022 and bottomed at -$1.68 in Q2 2021.
  • Average EPS (Weighted Average and Diluted) over 5 years is -$0.07, with a median of $0.03 recorded in 2023.
  • Peak YoY movement for EPS (Weighted Average and Diluted): plummeted 3460.0% in 2021, then surged 300.0% in 2023.
  • A 5-year view of EPS (Weighted Average and Diluted) shows it stood at -$0.12 in 2021, then surged by 233.33% to $0.16 in 2022, then tumbled by 81.25% to $0.03 in 2023, then changed by 0.0% to $0.03 in 2024, then soared by 166.67% to $0.08 in 2025.
  • Per Business Quant database, its latest 3 readings for EPS (Weighted Average and Diluted) were $0.08 in Q4 2025, $0.05 in Q3 2025, and $0.02 in Q2 2025.